Navigation Links
For Release: Esco Announces 2nd North American Facility in Marietta, OH
Date:12/11/2009

Hatboro, PA December 11, 2009 -- Esco announces the opening of a NEW 2nd North American facility in Marietta, OH. The facility will serve as a technical service, training and logistics center to support Esco's growth in the North American market, specifically in the area of New Product Introductions (NPI) for temperature-controlled laboratory equipment.

Hatboro, PA (PRWEB) December 11, 2009 -- Esco announces the opening of a NEW 2nd North American facility in Marietta, OH. The facility will serve as a technical service, training and logistics center to support Esco's growth in the North American market, specifically in the area of New Product Introductions (NPI) for temperature-controlled laboratory equipment.

"The new facility demonstrates Esco's commitment to the North American market," said XQ Lin, Esco President. "Furthermore, the Marietta, Ohio facility enables Esco to access local talent with unique skills in the area of temperature-controlled laboratory equipment."

About Esco:
Since 1978, Esco has emerged as a leader in the development of controlled environment, laboratory and cleanroom equipment solutions. Products sold in more than 100 countries include air showers, biological safety cabinets, downflow booths, ductless fume hoods, fan filter units, hospital pharmacy isolators, IVF workstations, lab animal research products, laboratory fume hoods, laboratory incubators, laboratory ovens, laminar flow cabinets, microplate shaker/incubators, modular cleanrooms, PCR cabinets, thermal cyclers and instrumentation, and powder weighing balance enclosures.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3316794.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1

Related biology technology :

1. Continental Whos Who Executive Press Release: David C. Galloway
2. News Release: Homeland Security to Take Centre Stage with Global Security Asia 2009
3. Dendreon Announces Pricing of Common Stock Offering
4. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
5. Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Sirius Genomics Announces Change in Leadership
7. AEterna Zentaris Announces Appointment of New Board Member
8. BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes
9. Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas
10. Dendreon Announces Proposed Public Offering of Common Stock
11. Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
For Release: Esco Announces 2nd North American Facility in Marietta, OH 
(Date:1/20/2017)... , January 20, 2017 ... cancer is one of leading causes of death worldwide. ... Although the number of cancer related deaths increased gradually ... Rising in incidence rate of various cancers continues to ... a research report by Global Market Insights, Inc. cancer ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)...  ArmaGen, Inc., today announced that it has ... executive officer, as well as a member of ... more than 17 years of executive management experience ... and pharmaceuticals. "Mathias is a ... skillset necessary to lead ArmaGen to its next ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... of drug and device development, and Prism Clinical Research , a leader ... announced Verified Clinical Trials (VCT) has been selected by both companies ...
Breaking Biology Technology:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):